Development of Insulin-like peptide 5 (INSL5) peptide analogues as novel therapeutics

开发胰岛素样肽 5 (INSL5) 肽类似物作为新型疗法

• 批准号: LP120100654
• 负责人: A/Prof Richard Hughes
• 金额: $ 18.6万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-11-30 至 2016-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP120100654
• 关键词: Development; Insulin; like; peptide; INSL5

Insulin-like peptide 5 (INSL5) is a naturally-occurring hormone in the body that likely plays a role in the control of appetite. This project aims to develop new molecules based on INSL5 that could be suitable for use as drugs to treat various appetite-related disorders, such as obesity (where patients eat too much) or anorexia (where patients eat too little).

胰岛素样肽5(INSL5)是体内一种自然产生的激素，可能在控制食欲方面发挥作用。该项目旨在开发基于INSL5的新分子，可用于治疗各种与食欲相关的疾病，如肥胖(患者吃得太多)或厌食症(患者吃得太少)。